会员登陆 | 会员注册 | 忘记密码
当前位置: 网站首页 >> 新闻资讯 >> 科研与科普 >> 查看详情


免疫细胞治疗系列文章(持续更新中。。。)

  • 发布时间:2018-02-08
  • 浏 览:200次

深圳市细胞治疗技术协会将会为大家持续提供最新的细胞治疗类相关的文献,方便大家下载!...

CAR-NK细胞治疗系列文章

Development of GPC3-specific Chimeric Antigen Receptor-engineered Natural Killer(2017)
Continuously expanding CAR NK-92 cells display selective cytotoxicity(2017)
Engineering Natural Killer Cells for Cancer Immunotherapy(2017)
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR(2017)
DAP12-Based Activating Chimeric Antigen Receptor for NK Cell (2017)
A combinational therapy of EGFR-CAR NK cells and oncolytic(2016)
CD19-CAR engineered NK-92 cells are sufficient to overcome(2016)
Dual targeting of glioblastoma with chimeric antigen receptor-engineered(2016)
Efficient generation of gene-modified human natural killer(2016)
AdvantagesandapplicationsofCAR-expressingnaturalkillercells(2015)
CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII(2015)
Engineering NK cells modified with an EGFRvIII-specific chimeric antigen receptor(2015)
Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing(2015)
Utilizing chimeric antigen receptors to direct natural killer cell activity(2015)
Are natural killer cells superior CAR drivers(2014)
Enhanced Cytotoxicity of Natural Killer Cells following the Acquisition(2014)
Targeting CD20t Aggressive B-cell Non–Hodgkin Lymphoma by Anti-CD20 CAR(2014)
CS1-Specific Chimeric Antigen Receptor (CAR)-Engineered Natural Killer Cells(2013)
Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen(2013)
Transfection of chimeric anti-CD138 gene enhances natural killer cell(2013)
NK cells engineered to express a GD2-specific antigen receptor(2012)
Comparison of mRNA and lentiviral based transfection of natural(2012)
Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell(2009)



CAR-T细胞治疗系列文章

A Milestone for CAR T Cells(2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells(2017)
Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma(2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma(2017)
Biopolymers codelivering engineered T cells and STING agonists(2017)
CD22-targeted CAR T cells induce remission in B-ALL(2017)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia(2017)
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform(2017)
Engineering T Cells with Customized Therapeutic Response Programs(2017)
HIV-1-Specific Chimeric Antigen Receptors Based on Broadly-Neutralizing Antibodies(2017)
Improving Chimeric Antigen Receptor-Modified TCell FunctionbyReversing (2017)
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers(2017)
Long-term persistence and function of hematopoietic stem cell-derived (2017)
Reengineering chimeric antigen receptor T cells for targeted therapy (2017)
Supraphysiologic control over HIV-1 replication mediated by CD8 T cells(2017)
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape(2017)
Targeting a CAR to the TRAC locus with CRISPRCas9 enhances tumour rejection(2017)
Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+(2016)

上一资讯:没有了